SeaSpine posted fourth-quarter revenue of $43.7 million, an increase of 15 percent year over year. Read more.
A Stryker subsidiary extended the cash tender offer for all outstanding shares of Wright Medical Group, which Stryker plans to acquire.
Biopharmaceutical company DiscGenics recently finished enrollment for its clinical trial of IDCT, an allogeneic, injectable disc cell therapy for degenerative disc disease.
Implanet recently appointed Stephan Collardey as country manager of its German subsidiary Implanet GmbH to accelerate its commercial and business operations.
The FDA on March 3 granted Life Spine 510(k) clearance for its Lateral Prolift Expandable System.
The FlareHawk expandable cage, developed by Integrity Implants, demonstrated efficient fusion rates in a recent retrospective study.
The AO Foundation and Icotec reached a deal to develop a spinal stabilization system using Icotec’s carbon/PEEK composite implant material.
Biomaterial company Sintx Technologies appointed orthopedic surgeon Mark Froimson, MD, to its board of directors on March 2.
Preston Wells, vice president of financial planning and analysis at Stryker, will assume the role of vice president of investor relations June 1.
Spinal devicemaker Viseon received $18 million in series B financing it will use for product development and other processes.
More articles on devices:
3 ways to improve ASC revenue cycle performance
Indiana legislators meet resistance on price transparency bill
Maximizing reimbursements in ASCs: A review of reimbursement methodology
